Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
SYMZF Symax Lift Holding Co Ltd
SPR Spirit AeroSystems Holdings Inc
AHICF Asahi Intecc Co Ltd
OCBM Preferred Commerce Inc
TASEF Tasman Resources Ltd
RM Regional Management Corp
DTK Deutsche Bank Contingent Capital Trust III
Q Quintiles Transnational Holdings Inc
SMP Standard Motor Products Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of unique ribonucleic acid (RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company is primarily focused on advancing the development of its potentially disease-modifying Duchenne Muscular Dystrophy (DMD) drug candidates, including its lead DMD product candidate, eteplirsen, which is an antisense PMO therapeutic in Phase III clinical development for the treatment of individuals with DMD who have an error in the gene coding for dystrophin that is amenable to skipping exon 51. The Company is also developing therapeutics using its technology for the treatment of drug-resistant bacteria and infectious, rare and other human diseases.

Price
Delayed
$11.48
Day's Change
0.30 (2.68%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.93
Day's Low
11.01
Volume
(Light)

Today's volume of 793,689 shares is on pace to be much lighter than SRPT's 10-day average volume of 1,413,600 shares.

793,689
  • Prev Close
    11.18
  • Today's Open
    11.01
  • Day's Range
    11.01-11.93
  • Avg Vol (10-day)
    1.4M
  • Last (time)
    2:39p ET 02/10/16
  • Last (size)
    100
  • 52-Wk Range
    10.20 - 41.97
    LowHigh
  • (10/05/15 - 02/09/16)
    12.55%
  • 114.0%
  • Market Cap
    519.7M
  • Shares Outstanding
    45.3M
  • -4.83
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 57.03
  • (% of float 01/29/16)
    27.72

Latest News

Today's News, February 10, 2016
11:02 am ET
Zacks
Yesterday's News, February 09, 2016
3:30 pm ET
Zacks
February 08, 2016
8:30 am ET
BusinessWire
February 04, 2016
9:31 am ET
PR Newswire
February 02, 2016
5:00 pm ET
BusinessWire
January 26, 2016
5:30 pm ET
BusinessWire
January 25, 2016
9:31 am ET
PR Newswire
January 22, 2016
7:47 pm ET
PR Newswire
January 20, 2016
10:09 pm ET
BusinessWire
7:42 pm ET
BusinessWire
3:50 pm ET
Zacks
6:30 am ET
Globe Newswire
January 19, 2016
9:00 am ET
PR Newswire
8:03 am ET
MarketWatch
8:03 am ET
MarketWatch
January 18, 2016
2:35 pm ET
Zacks
January 16, 2016
9:01 pm ET
BusinessWire
January 15, 2016
3:46 pm ET
BusinessWire
2:25 pm ET
Zacks
1:57 pm ET
BusinessWire
11:32 am ET
MarketWatch
11:02 am ET
PR Newswire
10:17 am ET
PR Newswire
10:10 am ET
MarketWatch
January 12, 2016
9:31 am ET
PR Newswire
January 07, 2016
12:17 pm ET
Zacks
January 04, 2016
4:30 pm ET
BusinessWire
December 30, 2015
4:25 pm ET
Zacks
9:31 am ET
PR Newswire
December 21, 2015
4:20 pm ET
Zacks
December 18, 2015
7:04 am ET
BusinessWire
December 16, 2015
9:31 am ET
PR Newswire
December 01, 2015
5:41 pm ET
BusinessWire
November 25, 2015
1:30 pm ET
Zacks
November 23, 2015
12:40 pm ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.